Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.12 trillion and total revenue of $109.89 billion.
Market Cap
1.12T
Revenue
109.89B
Profits
-41.29B
PE Ratio
n/a
Profit Margin
-37.58%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.92B | -0.03% | 924,189 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.28B | 0.11% | 717,781 | 14.92B |
| 3 | ARGX | argenx SE | 56.42B | -0.60% | 333,160 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.76B | -2.26% | 1,420,051 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 32.71B | 3.11% | 1,581,069 | - |
| 6 | RPRX | Royalty Pharma plc | 31.60B | -0.76% | 3,185,529 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 29.40B | 1.62% | 260,964 | 5.70B |
| 8 | BNTX | BioNTech SE | 22.90B | 1.12% | 1,130,846 | 3.23B |
| 9 | INCY | Incyte Corporation | 21.68B | 0.65% | 1,488,908 | 5.36B |
| 10 | ROIV | Roivant Sciences Ltd. | 21.61B | 1.04% | 5,306,033 | 8.26M |
| 11 | INSM | Insmed Incorporated | 21.21B | 1.17% | 4,529,094 | 819.56M |
| 12 | MRNA | Moderna, Inc. | 19.80B | 0.54% | 5,081,172 | 2.23B |
| 13 | GMAB | Genmab A/S | 15.40B | -0.63% | 1,113,722 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.47B | -2.38% | 635,791 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 13.54B | 1.14% | 405,009 | 998.25M |
| 16 | EXEL | Exelixis, Inc. | 13.35B | -0.69% | 1,584,588 | 2.38B |
| 17 | AXSM | Axsome Therapeutics, Inc. | 13.13B | 0.55% | 441,739 | 708.24M |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.08B | -1.11% | 1,545,540 | 579.96M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.11B | -0.74% | 1,964,868 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.08B | 1.37% | 207,462 | 1.13B |
| 21 | SMMT | Summit Therapeutics Inc. | 10.87B | 7.11% | 9,878,230 | - |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.81B | 0.74% | 1,099,930 | 3.24B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.50B | 0.15% | 1,182,203 | 622.01M |
| 24 | NUVL | Nuvalent, Inc. | 9.74B | -0.16% | 7,237,354 | - |
| 25 | CYTK | Cytokinetics, Incorporated | 9.52B | 1.27% | 1,292,938 | 105.82M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.37B | -1.11% | 313,521 | 417.30M |
| 27 | CORT | Corcept Therapeutics Incorporated | 8.90B | -0.41% | 719,110 | 769.10M |
| 28 | TECH | Bio-Techne Corporation | 8.45B | -0.04% | 2,558,198 | 1.21B |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.24B | -1.74% | 1,042,050 | 1.51B |
| 30 | ABVX | ABIVAX Société Anonyme | 7.85B | -4.28% | 1,164,027 | 5.67M |
| 31 | IBRX | ImmunityBio, Inc. | 7.44B | -1.39% | 8,816,048 | 140.98M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 7.43B | 7.50% | 423,174 | 7.46M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.09B | 3.91% | 625,228 | 51.48M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 7.06B | -0.01% | 448,850 | 74.06M |
| 35 | TGTX | TG Therapeutics, Inc. | 7.02B | 3.06% | 2,548,927 | 700.35M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 7.02B | 0.02% | 958,742 | - |
| 37 | IMVT | Immunovant, Inc. | 6.90B | 2.25% | 1,136,774 | - |
| 38 | PCVX | Vaxcyte, Inc. | 6.85B | 0.36% | 1,030,994 | - |
| 39 | LEGN | Legend Biotech Corporation | 6.66B | -1.13% | 1,700,480 | 1.14B |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.62B | -1.31% | 1,302,759 | - |
| 41 | PTCT | PTC Therapeutics, Inc. | 6.23B | 0.58% | 1,074,606 | 827.11M |
| 42 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.13% | 1,322,754 | 15.00M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.06B | -0.20% | 553,578 | 569.61M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.06B | 0.82% | 554,449 | 217.17M |
| 45 | COGT | Cogent Biosciences, Inc. | 5.66B | 1.47% | 1,480,114 | - |
| 46 | BLTE | Belite Bio, Inc | 5.44B | 0.96% | 154,909 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.29B | -1.14% | 1,154,642 | - |
| 48 | CGON | CG Oncology, Inc. | 5.25B | 3.33% | 933,767 | 5.07M |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.12B | 0.38% | 247,086 | 274.48M |
| 50 | CAI | Caris Life Sciences, Inc. | 5.08B | -0.17% | 1,984,380 | 907.29M |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.04B | -0.17% | 704,212 | 7.50M |
| 52 | TVTX | Travere Therapeutics, Inc. | 4.84B | 6.40% | 2,389,045 | 536.20M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.80B | -0.86% | 1,150,878 | 4.10M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.49B | 7.35% | 1,381,056 | 1.34M |
| 55 | TNGX | Tango Therapeutics, Inc. | 4.48B | 3.76% | 9,962,709 | 56.99M |
| 56 | ERAS | Erasca, Inc. | 4.37B | 0.29% | 2,078,145 | - |
| 57 | CELC | Celcuity Inc. | 4.32B | -1.05% | 1,532,973 | - |
| 58 | ORKA | Oruka Therapeutics, Inc. | 4.22B | 2.07% | 781,479 | - |
| 59 | MANE | Veradermics, Incorporated | 4.01B | 1.77% | 260,393 | - |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | -0.03% | 826,904 | 596.96M |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 3.75B | 2.65% | 927,413 | - |
| 62 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.63B | 2.80% | 1,039,511 | 18.07M |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.61B | -1.40% | 753,938 | 1.10B |
| 64 | NAMS | NewAmsterdam Pharma Company N.V. | 3.55B | 0.46% | 673,541 | 22.57M |
| 65 | PBLS | Parabilis Medicines, Inc. | 3.47B | -10.06% | 1,035,959 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.44B | 3.04% | 2,189,157 | - |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.34B | 0.49% | 1,177,602 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.30B | 1.16% | 386,781 | 803.79M |
| 69 | RLAY | Relay Therapeutics, Inc. | 3.23B | 4.00% | 1,770,195 | 10.68M |
| 70 | ALMS | Alumis Inc. | 3.08B | 15.55% | 2,247,108 | 8.40M |
| 71 | GPCR | Structure Therapeutics Inc. | 3.05B | -0.85% | 545,990 | - |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | -0.85% | 1,329,450 | 415.62M |
| 73 | DYN | Dyne Therapeutics, Inc. | 3.01B | 1.34% | 926,841 | - |
| 74 | RCUS | Arcus Biosciences, Inc. | 2.99B | 2.15% | 1,447,474 | 236.00M |
| 75 | BEAM | Beam Therapeutics Inc. | 2.89B | -1.29% | 1,588,380 | 164.01M |
| 76 | ELVN | Enliven Therapeutics, Inc. | 2.81B | 14.30% | 6,146,000 | - |
| 77 | DFTX | Definium Therapeutics, Inc. | 2.70B | 2.65% | 1,727,489 | - |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 2.67B | -1.05% | 267,323 | 535.08M |
| 79 | IRON | Disc Medicine, Inc. | 2.60B | -0.13% | 184,471 | - |
| 80 | IDYA | IDEAYA Biosciences, Inc. | 2.55B | 0.49% | 617,365 | 225.27M |
| 81 | VERA | Vera Therapeutics, Inc. | 2.46B | 1.81% | 901,692 | - |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.45B | 4.37% | 599,807 | 865.00K |
| 83 | KLRA | Kailera Therapeutics, Inc. | 2.45B | -3.33% | 411,683 | - |
| 84 | RARE | Ultragenyx Pharmaceutical Inc. | 2.39B | 1.54% | 1,846,693 | 670.00M |
| 85 | PHVS | Pharvaris N.V. | 2.14B | -4.60% | 180,201 | - |
| 86 | KOD | Kodiak Sciences Inc. | 2.13B | 0.26% | 630,099 | - |
| 87 | IMNM | Immunome, Inc. | 2.08B | 0.11% | 2,066,386 | 4.02M |
| 88 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | -0.19% | 673,685 | 298.30M |
| 89 | TRVI | Trevi Therapeutics, Inc. | 2.02B | 5.57% | 1,513,465 | - |
| 90 | NKTR | Nektar Therapeutics | 2.01B | 0.29% | 534,203 | 55.63M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 1.99B | -2.10% | 693,306 | 899.11M |
| 92 | OCUL | Ocular Therapeutix, Inc. | 1.96B | 2.76% | 2,696,811 | 52.04M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | -1.34% | 1,818,316 | - |
| 94 | ZLAB | Zai Lab Limited | 1.92B | -3.23% | 1,305,390 | 453.28M |
| 95 | VCEL | Vericel Corporation | 1.91B | -2.88% | 364,973 | 292.09M |
| 96 | ADMA | ADMA Biologics, Inc. | 1.90B | -1.32% | 3,024,296 | 509.86M |
| 97 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -0.14% | 91,349 | 1.20B |
| 98 | STOK | Stoke Therapeutics, Inc. | 1.86B | 1.57% | 478,898 | 32.08M |
| 99 | RAPP | Rapport Therapeutics, Inc. | 1.84B | 9.06% | 255,654 | 20.00M |
| 100 | IOVA | Iovance Biotherapeutics, Inc. | 1.82B | 3.03% | 10,969,942 | 285.61M |
| 101 | VRDN | Viridian Therapeutics, Inc. | 1.81B | 1.30% | 1,247,301 | 70.92M |
| 102 | NBTX | Nanobiotix S.A. | 1.80B | 0.59% | 84,271 | 38.27M |
| 103 | MESO | Mesoblast Limited | 1.78B | -1.35% | 116,369 | 65.38M |
| 104 | NRIX | Nurix Therapeutics, Inc. | 1.75B | -0.18% | 2,562,931 | 71.78M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.75B | 2.58% | 1,141,117 | 66.05M |
| 106 | QURE | uniQure N.V. | 1.74B | 2.80% | 836,739 | 18.09M |
| 107 | NUVB | Nuvation Bio Inc. | 1.71B | 3.36% | 5,250,474 | 143.05M |
| 108 | BHVN | Biohaven Ltd. | 1.70B | -0.79% | 2,361,335 | - |
| 109 | NTLA | Intellia Therapeutics, Inc. | 1.69B | -1.94% | 10,223,429 | 66.09M |
| 110 | MBX | MBX Biosciences, Inc. | 1.69B | -4.67% | 2,155,677 | - |
| 111 | INVA | Innoviva, Inc. | 1.68B | 1.34% | 557,733 | 420.69M |
| 112 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | - | 14,837,647 | 66.41M |
| 113 | ZYME | Zymeworks Inc. | 1.67B | -0.39% | 522,957 | 81.26M |
| 114 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | 2.33% | 2,048,635 | 7.47M |
| 115 | AAPG | Ascentage Pharma Group International | 1.64B | 2.86% | 11,877 | 82.08M |
| 116 | ANAB | AnaptysBio, Inc. | 1.63B | 3.37% | 422,711 | 232.39M |
| 117 | SION | Sionna Therapeutics, Inc. | 1.62B | -0.36% | 189,641 | - |
| 118 | SEPN | Septerna, Inc. | 1.62B | 5.64% | 475,864 | 72.26M |
| 119 | SNDX | Syndax Pharmaceuticals, Inc. | 1.62B | 1.90% | 1,048,629 | 217.17M |
| 120 | SRPT | Sarepta Therapeutics, Inc. | 1.62B | 2.07% | 2,270,569 | 2.18B |
| 121 | TYRA | Tyra Biosciences, Inc. | 1.61B | 5.55% | 1,013,845 | - |
| 122 | ABCL | AbCellera Biologics Inc. | 1.60B | -0.57% | 2,959,095 | 79.21M |
| 123 | GENB | Generate Biomedicines, Inc. | 1.59B | -4.25% | 688,706 | 30.30M |
| 124 | PGEN | Precigen, Inc. | 1.59B | -1.77% | 4,562,399 | 31.60M |
| 125 | PVLA | Palvella Therapeutics, Inc. | 1.56B | 2.28% | 360,812 | - |
| 126 | FTRE | Fortrea Holdings Inc. | 1.56B | -2.31% | 964,668 | 2.71B |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.54B | 6.64% | 1,092,851 | 42.95M |
| 128 | CAPR | Capricor Therapeutics, Inc. | 1.49B | 3.04% | 773,705 | 11.13M |
| 129 | IMCR | Immunocore Holdings plc | 1.47B | 1.19% | 276,831 | 412.81M |
| 130 | NVAX | Novavax, Inc. | 1.46B | -1.66% | 2,592,148 | 596.34M |
| 131 | SLS | SELLAS Life Sciences Group, Inc. | 1.46B | 1.03% | 4,089,539 | - |
| 132 | VIR | Vir Biotechnology, Inc. | 1.45B | 1.06% | 1,177,220 | 65.50M |
| 133 | GHRS | GH Research PLC | 1.45B | 2.23% | 181,085 | - |
| 134 | URGN | UroGen Pharma Ltd. | 1.45B | 0.75% | 585,046 | 140.49M |
| 135 | ATAI | AtaiBeckley Inc. | 1.44B | 3.16% | 4,992,218 | 3.49M |
| 136 | BCAX | Bicara Therapeutics Inc. | 1.43B | 1.93% | 418,876 | - |
| 137 | AVBP | ArriVent BioPharma, Inc. | 1.42B | 1.13% | 448,157 | - |
| 138 | ARDX | Ardelyx, Inc. | 1.41B | -1.73% | 2,628,436 | 427.68M |
| 139 | MLTX | MoonLake Immunotherapeutics | 1.38B | 5.30% | 738,567 | - |
| 140 | INBX | Inhibrx Biosciences, Inc. | 1.35B | -1.43% | 263,338 | 1.30M |
| 141 | SVRA | Savara Inc. | 1.33B | -0.19% | 1,252,741 | - |
| 142 | MAZE | Maze Therapeutics, Inc. | 1.33B | -0.17% | 596,579 | 20.00M |
| 143 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.29B | -4.41% | 1,675,471 | 204.73M |
| 144 | IMTX | Immatics N.V. | 1.28B | 3.53% | 376,663 | 43.00M |
| 145 | DMRA | Damora Therapeutics, Inc. | 1.28B | -2.72% | 207,156 | - |
| 146 | MPLT | MapLight Therapeutics, Inc. | 1.26B | -8.57% | 324,401 | - |
| 147 | AVLN | Avalyn Pharma Inc. | 1.26B | 7.16% | 286,487 | - |
| 148 | ZBIO | Zenas BioPharma, Inc. | 1.25B | 11.49% | 1,322,248 | 10.00M |
| 149 | AKTS | Aktis Oncology, Inc. | 1.21B | 12.69% | 848,717 | 8.28M |
| 150 | MNKD | MannKind Corporation | 1.13B | -2.40% | 3,844,284 | 360.78M |
| 151 | WVE | Wave Life Sciences Ltd. | 1.13B | 1.03% | 2,245,032 | 71.80M |
| 152 | COAG | Hemab Therapeutics Holdings, Inc. | 1.10B | -7.28% | 168,757 | - |
| 153 | EYPT | EyePoint, Inc. | 1.09B | 4.24% | 1,093,548 | 7.61M |
| 154 | ABSI | Absci Corporation | 1.06B | 4.45% | 4,468,142 | 1.84M |
| 155 | DBVT | DBV Technologies S.A. | 1.03B | 5.29% | 991,701 | 5.74M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 1.00B | 2.84% | 1,023,218 | - |
| 157 | SPRY | ARS Pharmaceuticals, Inc. | 969.20M | 1.77% | 1,328,324 | 98.99M |
| 158 | SPTX | Seaport Therapeutics, Inc. | 954.50M | 1.58% | 99,622 | - |
| 159 | XNCR | Xencor, Inc. | 914.17M | 1.99% | 591,564 | 97.36M |
| 160 | PHAR | Pharming Group N.V. | 911.33M | -0.58% | 6,849 | 369.49M |
| 161 | JBIO | Jade Biosciences, Inc. | 910.58M | -4.60% | 1,046,552 | - |
| 162 | DRTS | Alpha Tau Medical Ltd. | 888.23M | 1.76% | 857,472 | - |
| 163 | MGTX | MeiraGTx Holdings plc | 888.13M | -0.10% | 465,358 | 79.76M |
| 164 | OLMA | Olema Pharmaceuticals, Inc. | 862.12M | 1.23% | 1,600,068 | - |
| 165 | TBPH | Theravance Biopharma, Inc. | 857.84M | 0.91% | 230,170 | 109.78M |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 856.09M | 5.75% | 1,561,550 | - |
| 167 | LXRX | Lexicon Pharmaceuticals, Inc. | 852.86M | 1.59% | 2,994,453 | 69.64M |
| 168 | CGEM | Cullinan Therapeutics, Inc. | 841.98M | 5.55% | 1,318,279 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 841.51M | -0.70% | 1,011,472 | 191.45M |
| 170 | JANX | Janux Therapeutics, Inc. | 826.95M | -0.73% | 860,415 | 13.73M |
| 171 | PHAT | Phathom Pharmaceuticals, Inc. | 823.69M | 0.97% | 554,284 | 204.89M |
| 172 | IVA | Inventiva S.A. | 822.46M | 1.32% | 1,009,393 | 7.94M |
| 173 | LBRX | LB Pharmaceuticals Inc | 814.99M | -0.42% | 158,397 | - |
| 174 | SANA | Sana Biotechnology, Inc. | 803.73M | -3.25% | 2,254,676 | - |
| 175 | KURA | Kura Oncology, Inc. | 803.41M | 2.14% | 1,295,220 | 71.64M |
| 176 | ODTX | Odyssey Therapeutics, Inc. | 797.24M | 0.54% | 250,394 | 2.98M |
| 177 | VOR | Vor Biopharma Inc. | 778.11M | 1.92% | 545,065 | - |
| 178 | AVTX | Avalo Therapeutics, Inc. | 775.87M | 7.97% | 1,120,669 | 59.00K |
| 179 | ANNX | Annexon, Inc. | 771.70M | 0.21% | 3,196,199 | - |
| 180 | ANRO | Alto Neuroscience, Inc. | 753.47M | 0.19% | 272,048 | - |
| 181 | ZVRA | Zevra Therapeutics, Inc. | 747.81M | -2.47% | 1,720,014 | 122.29M |
| 182 | GERN | Geron Corporation | 737.75M | 0.88% | 8,110,735 | 196.12M |
| 183 | REPL | Replimune Group, Inc. | 733.24M | 3.02% | 1,972,916 | - |
| 184 | EVMN | Evommune, Inc. | 714.24M | -4.16% | 462,728 | 10.00M |
| 185 | AURA | Aura Biosciences, Inc. | 707.02M | 3.22% | 959,156 | - |
| 186 | SLDB | Solid Biosciences Inc. | 702.93M | -1.11% | 1,664,864 | - |
| 187 | RLMD | Relmada Therapeutics, Inc. | 697.52M | 1.99% | 1,127,914 | - |
| 188 | CRMD | CorMedix Inc. | 685.67M | -2.46% | 969,814 | 400.05M |
| 189 | DSGN | Design Therapeutics, Inc. | 685.15M | 4.18% | 562,645 | - |
| 190 | TENX | Tenax Therapeutics, Inc. | 675.92M | 6.99% | 1,767,804 | - |
| 191 | OCS | Oculis Holding AG | 669.70M | 0.82% | 406,882 | 1.40M |
| 192 | ALLO | Allogene Therapeutics, Inc. | 655.79M | 1.06% | 8,642,431 | 22.00K |
| 193 | CTMX | CytomX Therapeutics, Inc. | 655.29M | 1.01% | 2,050,213 | 35.54M |
| 194 | OMER | Omeros Corporation | 632.20M | -14.19% | 7,784,719 | 9.89M |
| 195 | CADL | Candel Therapeutics, Inc. | 627.19M | 4.90% | 1,361,837 | - |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 620.83M | 3.89% | 227,617 | - |
| 197 | SGP | SpyGlass Pharma, Inc. | 616.39M | 1.93% | 57,083 | - |
| 198 | TRAX | First Tracks Biotherapeutics, Inc. | 615.50M | 3.58% | 415,307 | - |
| 199 | RIGL | Rigel Pharmaceuticals, Inc. | 607.79M | 2.40% | 241,692 | 299.77M |
| 200 | ACRS | Aclaris Therapeutics, Inc. | 603.35M | -1.14% | 1,114,530 | 8.37M |
| 201 | DRUG | Bright Minds Biosciences Inc. | 598.77M | -1.01% | 658,919 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 595.46M | -2.29% | 181,955 | 11.88M |
| 203 | IMMX | Immix Biopharma, Inc. | 589.73M | 4.32% | 1,106,336 | - |
| 204 | TECX | Tectonic Therapeutic, Inc. | 571.36M | 3.20% | 101,573 | - |
| 205 | ACHV | Achieve Life Sciences, Inc. | 566.68M | - | 1,172,804 | - |
| 206 | CLYM | Climb Bio, Inc. | 546.47M | 4.86% | 858,994 | - |
| 207 | GYRE | Gyre Therapeutics, Inc. | 541.84M | -2.15% | 81,593 | 117.05M |
| 208 | MDXG | MiMedx Group, Inc. | 536.20M | -2.44% | 947,120 | 389.42M |
| 209 | XOMA | XOMA Royalty Corporation | 524.09M | -0.02% | 129,397 | 48.56M |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 515.41M | -1.38% | 697,179 | 151.40M |
| 211 | ALT | Altimmune, Inc. | 507.58M | 0.77% | 2,144,903 | 36.00K |
| 212 | VRXA | VERAXA Biotech AG | 504.35M | -19.32% | 24,722 | - |
| 213 | VALN | Valneva SE | 501.95M | 1.23% | 24,775 | 180.25M |
| 214 | PRME | Prime Medicine, Inc. | 501.21M | -1.60% | 1,710,032 | 4.03M |
| 215 | PROK | ProKidney Corp. | 495.38M | -1.20% | 774,800 | 889.00K |
| 216 | CABA | Cabaletta Bio, Inc. | 490.79M | - | 2,915,535 | - |
| 217 | ARVN | Arvinas, Inc. | 489.07M | 6.91% | 858,474 | 89.40M |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 487.57M | 2.35% | 646,650 | - |
| 219 | STRO | Sutro Biopharma, Inc. | 477.23M | 8.76% | 148,282 | 99.61M |
| 220 | EIKN | Eikon Therapeutics, Inc. | 473.71M | 2.70% | 228,923 | - |
| 221 | AGMB | AgomAb Therapeutics NV | 473.27M | -2.73% | 80,724 | - |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 461.60M | -0.11% | 560,414 | 88.24M |
| 223 | NGNE | Neurogene Inc. | 459.84M | 0.34% | 112,542 | 925.00K |
| 224 | ASMB | Assembly Biosciences, Inc. | 455.00M | 1.91% | 144,395 | 71.10M |
| 225 | PRLD | Prelude Therapeutics Incorporated | 445.31M | 9.25% | 315,410 | 16.72M |
| 226 | CTNM | Contineum Therapeutics, Inc. | 444.15M | 0.17% | 109,471 | - |
| 227 | PRTA | Prothena Corporation plc | 431.91M | -0.12% | 315,405 | 57.94M |
| 228 | CCCC | C4 Therapeutics, Inc. | 431.21M | 0.78% | 2,849,694 | 34.86M |
| 229 | OVID | Ovid Therapeutics Inc. | 429.27M | 4.07% | 2,061,967 | 7.12M |
| 230 | FBRX | Forte Biosciences, Inc. | 429.09M | 0.92% | 219,297 | - |
| 231 | RZLT | Rezolute, Inc. | 417.87M | 3.63% | 1,312,012 | - |
| 232 | AUTL | Autolus Therapeutics plc | 415.18M | - | 1,019,732 | 92.62M |
| 233 | ARTV | Artiva Biotherapeutics, Inc. | 414.94M | 6.75% | 1,432,298 | 251.00K |
| 234 | ANL | Adlai Nortye Ltd. | 412.80M | 1.18% | 55,008 | 5.00M |
| 235 | OCGN | Ocugen, Inc. | 409.61M | -0.82% | 3,743,289 | 4.47M |
| 236 | VTVT | vTv Therapeutics Inc. | 406.60M | 3.72% | 60,731 | 36.84M |
| 237 | IPSC | Century Therapeutics, Inc. | 405.80M | 0.45% | 702,375 | 109.16M |
| 238 | INDP | Indaptus Therapeutics, Inc. | 405.41M | 0.28% | 588,684 | - |
| 239 | MNPR | Monopar Therapeutics Inc. | 400.39M | 1.13% | 154,407 | - |
| 240 | SGMT | Sagimet Biosciences Inc. | 400.15M | 0.78% | 460,277 | - |
| 241 | EPRX | Eupraxia Pharmaceuticals Inc. | 395.37M | 0.17% | 141,123 | - |
| 242 | BNTC | Benitec Biopharma Inc. | 384.08M | 1.18% | 73,919 | - |
| 243 | EDIT | Editas Medicine, Inc. | 383.65M | 2.46% | 1,908,255 | 38.69M |
| 244 | STTK | Shattuck Labs, Inc. | 378.80M | 18.18% | 1,289,811 | 1.00M |
| 245 | XFOR | X4 Pharmaceuticals, Inc. | 377.28M | 3.09% | 501,561 | 9.01M |
| 246 | PBYI | Puma Biotechnology, Inc. | 373.09M | 1.38% | 260,994 | 227.18M |
| 247 | CMPX | Compass Therapeutics, Inc. | 365.58M | 1.00% | 2,049,689 | 850.00K |
| 248 | LRMR | Larimar Therapeutics, Inc. | 362.21M | -3.61% | 1,563,039 | - |
| 249 | VSTM | Verastem, Inc. | 360.28M | 4.06% | 1,600,078 | 49.59M |
| 250 | AVIR | Atea Pharmaceuticals, Inc. | 359.32M | 2.98% | 197,801 | - |
| 251 | GLSI | Greenwich LifeSciences, Inc. | 353.16M | 4.47% | 94,527 | - |
| 252 | VNDA | Vanda Pharmaceuticals Inc. | 353.00M | -3.77% | 1,320,319 | 217.78M |
| 253 | ZURA | Zura Bio Limited | 351.06M | 3.35% | 472,161 | - |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 346.03M | 3.39% | 190,272 | 69.21M |
| 255 | RGNX | REGENXBIO Inc. | 344.31M | 6.05% | 904,546 | 87.82M |
| 256 | LXEO | Lexeo Therapeutics, Inc. | 343.14M | 4.05% | 625,038 | - |
| 257 | UPB | Upstream Bio, Inc. | 331.96M | -4.39% | 1,432,202 | 3.32M |
| 258 | NMRA | Neumora Therapeutics, Inc. | 329.81M | - | 719,391 | - |
| 259 | OABI | OmniAb, Inc. | 329.09M | -2.99% | 217,648 | 28.94M |
| 260 | IRD | Opus Genetics, Inc. | 328.84M | 3.32% | 689,972 | 11.98M |
| 261 | LCTX | Lineage Cell Therapeutics, Inc. | 316.61M | -0.78% | 1,018,885 | 14.78M |
| 262 | SLN | Silence Therapeutics plc | 316.00M | 0.15% | 239,402 | 839.00K |
| 263 | ABEO | Abeona Therapeutics Inc. | 315.18M | - | 957,291 | 14.54M |
| 264 | LYEL | Lyell Immunopharma, Inc. | 315.01M | -1.60% | 99,935 | 31.00K |
| 265 | FENC | Fennec Pharmaceuticals Inc. | 312.63M | 1.69% | 251,263 | 51.00M |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 304.44M | 3.48% | 105,016 | - |
| 267 | RCKT | Rocket Pharmaceuticals, Inc. | 300.28M | 3.38% | 2,441,807 | - |
| 268 | PALI | Palisade Bio, Inc. | 286.30M | -3.93% | 2,182,042 | - |
| 269 | CNXU | Conexeu Sciences Inc. | 285.30M | -6.92% | 58,742 | - |
| 270 | NAUT | Nautilus Biotechnology, Inc. | 284.66M | -1.97% | 441,404 | - |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 284.61M | - | 424,716 | 1.00 |
| 272 | NVCT | Nuvectis Pharma, Inc. | 284.09M | 1.90% | 69,105 | - |
| 273 | BCYC | Bicycle Therapeutics plc | 282.74M | -1.22% | 767,609 | 63.50M |
| 274 | RNAC | Cartesian Therapeutics, Inc. | 279.42M | 17.99% | 877,999 | 1.78M |
| 275 | ARMP | Armata Pharmaceuticals, Inc. | 278.15M | 1.47% | 77,945 | 5.20M |
| 276 | ELDN | Eledon Pharmaceuticals, Inc. | 275.97M | - | 1,315,609 | - |
| 277 | NAGE | Niagen Bioscience, Inc. | 275.35M | 0.58% | 485,704 | 130.42M |
| 278 | ELTX | Elicio Therapeutics, Inc. | 273.18M | 6.53% | 125,444 | - |
| 279 | SRZN | Surrozen, Inc. | 271.57M | 0.09% | 71,099 | 7.49M |
| 280 | IMRX | Immuneering Corporation | 271.08M | 1.70% | 1,547,978 | - |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 266.95M | 6.53% | 889,964 | 26.87M |
| 282 | MGNX | MacroGenics, Inc. | 251.71M | -1.25% | 513,188 | 157.08M |
| 283 | OBIO | Orchestra BioMed Holdings, Inc. | 245.51M | 0.74% | 556,333 | 32.72M |
| 284 | FHTX | Foghorn Therapeutics Inc. | 245.42M | 2.96% | 157,716 | 28.22M |
| 285 | FATE | Fate Therapeutics, Inc. | 240.11M | 4.57% | 4,700,135 | 6.32M |
| 286 | SLGL | Sol-Gel Technologies Ltd. | 240.07M | -2.47% | 44,670 | 18.47M |
| 287 | ADAG | Adagene Inc. | 235.88M | -0.28% | 250,190 | 7.67M |
| 288 | IFRX | InflaRx N.V. | 235.67M | -4.76% | 773,886 | 33.82K |
| 289 | HUMA | Humacyte, Inc. | 234.23M | -2.31% | 9,087,132 | 2.02M |
| 290 | SABS | SAB Biotherapeutics, Inc. | 234.02M | -1.48% | 356,432 | 114.70K |
| 291 | TRDA | Entrada Therapeutics, Inc. | 232.78M | 2.38% | 185,971 | 5.74M |
| 292 | CLLS | Cellectis S.A. | 232.34M | - | 36,726 | 75.11M |
| 293 | AVXL | Anavex Life Sciences Corp. | 231.68M | - | 1,222,156 | - |
| 294 | YDES | YD Bio Limited | 229.95M | 0.62% | 15,375 | 510.36K |
| 295 | FULC | Fulcrum Therapeutics, Inc. | 229.88M | -2.82% | 1,344,486 | 80.00M |
| 296 | ACIU | AC Immune SA | 229.15M | 2.21% | 266,692 | 4.62M |
| 297 | IVVD | Invivyd, Inc. | 226.85M | -5.23% | 8,348,355 | 55.87M |
| 298 | TARA | Protara Therapeutics, Inc. | 219.20M | 6.85% | 524,548 | - |
| 299 | CDXS | Codexis, Inc. | 218.15M | -0.41% | 352,824 | 78.09M |
| 300 | CAMP | Camp4 Therapeutics Corporation | 217.57M | -0.71% | 41,032 | 3.93M |
| 301 | CHRS | Coherus Oncology, Inc. | 215.95M | -1.41% | 506,403 | 46.88M |
| 302 | CNTN | Canton Strategic Holdings, Inc. | 215.70M | 2.32% | 777,421 | - |
| 303 | HELP | Cybin Inc. | 215.15M | 6.17% | 519,338 | - |
| 304 | QTTB | Q32 Bio Inc. | 214.33M | -0.47% | 326,904 | 53.74M |
| 305 | KPTI | Karyopharm Therapeutics Inc. | 214.24M | 5.56% | 564,583 | 151.12M |
| 306 | ALXO | ALX Oncology Holdings Inc. | 212.60M | 3.95% | 642,637 | - |
| 307 | LENZ | LENZ Therapeutics, Inc. | 212.27M | 4.15% | 283,721 | 20.99M |
| 308 | RNA | Atrium Therapeutics, Inc. | 211.60M | -0.48% | 103,635 | 36.68M |
| 309 | VYGR | Voyager Therapeutics, Inc. | 211.47M | 1.16% | 540,804 | 36.49M |
| 310 | NERV | Minerva Neurosciences, Inc. | 210.12M | -2.38% | 83,000 | - |
| 311 | WHWK | Whitehawk Therapeutics, Inc. | 205.72M | 2.46% | 161,368 | 7.15M |
| 312 | NKTX | Nkarta, Inc. | 204.62M | 3.62% | 677,584 | - |
| 313 | NGEN | NervGen Pharma Corp. | 203.91M | 1.59% | 678,893 | - |
| 314 | KROS | Keros Therapeutics, Inc. | 200.89M | 1.00% | 178,205 | 33.18M |
| 315 | ARCT | Arcturus Therapeutics Holdings Inc. | 198.11M | - | 286,294 | 54.71M |
| 316 | UNCY | Unicycive Therapeutics, Inc. | 193.58M | -5.72% | 953,919 | - |
| 317 | CGEN | Compugen Ltd. | 192.95M | - | 206,978 | 72.66M |
| 318 | IMUX | Immunic, Inc. | 188.79M | 6.04% | 195,633 | - |
| 319 | MDWD | MediWound Ltd. | 182.76M | 0.92% | 48,049 | 14.48M |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 180.93M | 6.57% | 677,487 | 17.56M |
| 321 | TTRX | Turn Therapeutics Inc. | 180.07M | 3.16% | 55,854 | - |
| 322 | EQ | Equillium, Inc. | 177.67M | - | 441,294 | 4.39M |
| 323 | GALT | Galectin Therapeutics Inc. | 175.84M | 2.30% | 282,156 | - |
| 324 | MIST | Milestone Pharmaceuticals Inc. | 172.78M | - | 687,442 | 1.78M |
| 325 | NBP | NovaBridge Biosciences | 172.32M | 1.36% | 358,843 | - |
| 326 | ABOS | Acumen Pharmaceuticals, Inc. | 171.18M | - | 414,943 | - |
| 327 | ANTX | AN2 Therapeutics, Inc. | 170.62M | 6.52% | 192,706 | - |
| 328 | ALEC | Alector, Inc. | 169.87M | -2.55% | 263,831 | 18.42M |
| 329 | IPHA | Innate Pharma S.A. | 169.69M | 1.15% | 464,705 | 10.57M |
| 330 | OKUR | OnKure Therapeutics, Inc. | 169.66M | -1.18% | 175,730 | - |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 168.39M | 1.95% | 254,955 | 76.38M |
| 332 | KRRO | Korro Bio, Inc. | 167.45M | 10.26% | 315,455 | 3.84M |
| 333 | SPRO | Spero Therapeutics, Inc. | 165.02M | 5.56% | 623,936 | 61.19M |
| 334 | KZIA | Kazia Therapeutics Limited | 163.18M | 13.88% | 167,825 | 1.27M |
| 335 | ENLV | Enlivex Ltd. | 161.53M | -6.80% | 180,138 | - |
| 336 | ORMP | Oramed Pharmaceuticals Inc. | 158.38M | 1.84% | 112,827 | 2.00M |
| 337 | CRBU | Caribou Biosciences, Inc. | 158.19M | -3.92% | 2,301,206 | 11.20M |
| 338 | DTIL | Precision BioSciences, Inc. | 157.39M | -1.13% | 236,184 | 45.07M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 154.46M | -1.11% | 1,416,303 | 225.00K |
| 340 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 151.74M | 5.27% | 574,890 | - |
| 341 | PRQR | ProQR Therapeutics N.V. | 151.72M | - | 315,934 | 15.73M |
| 342 | HURA | TuHURA Biosciences, Inc. | 147.74M | 5.94% | 436,821 | - |
| 343 | OTLK | Outlook Therapeutics, Inc. | 147.45M | 10.91% | 38,103,435 | 333.14K |
| 344 | SPRB | Spruce Biosciences, Inc. | 142.82M | 5.66% | 80,930 | 697.00K |
| 345 | MOLN | Molecular Partners AG | 142.81M | 10.78% | 1,848 | 856.30K |
| 346 | TLSA | Tiziana Life Sciences Ltd | 142.24M | -2.65% | 423,514 | - |
| 347 | NRXP | NRx Pharmaceuticals, Inc. | 138.99M | -2.04% | 598,317 | 2.29M |
| 348 | AGEN | Agenus Inc. | 137.42M | -2.65% | 505,336 | 123.87M |
| 349 | GUTS | Fractyl Health, Inc. | 134.85M | 17.42% | 3,105,976 | 3.00K |
| 350 | ADCT | ADC Therapeutics SA | 133.55M | -0.94% | 1,552,072 | 79.18M |
| 351 | CNTB | Connect Biopharma Holdings Limited | 133.48M | 0.95% | 173,605 | 233.00K |
| 352 | GNLX | Genelux Corporation | 131.45M | 2.78% | 116,192 | 8.00K |
| 353 | ACOG | Alpha Cognition Inc. | 130.43M | -0.83% | 46,799 | 10.83M |
| 354 | CNTX | Context Therapeutics Inc. | 127.71M | -2.11% | 498,819 | - |
| 355 | ALPS | Alps Group Inc | 120.61M | 0.67% | 5,055 | 3.74M |
| 356 | NTHI | NeOnc Technologies Holdings, Inc. | 120.25M | 5.56% | 643,011 | 39.99K |
| 357 | MENS | Jyong Biotech Ltd. | 117.29M | -7.33% | 199,850 | - |
| 358 | PLYX | Polaryx Therapeutics, Inc. | 112.20M | -0.42% | 52,611 | - |
| 359 | PYXS | Pyxis Oncology, Inc. | 111.51M | 5.39% | 437,524 | 13.86M |
| 360 | COYA | Coya Therapeutics, Inc. | 111.19M | 2.16% | 114,973 | 7.94M |
| 361 | ENGN | enGene Therapeutics Inc. | 108.52M | -1.22% | 458,509 | - |
| 362 | CGTX | Cognition Therapeutics, Inc. | 108.12M | 0.83% | 463,824 | - |
| 363 | ALDX | Aldeyra Therapeutics, Inc. | 106.17M | 2.92% | 831,672 | - |
| 364 | CRDF | Cardiff Oncology, Inc. | 105.29M | -3.14% | 806,794 | 525.00K |
| 365 | KLRS | Kalaris Therapeutics, Inc. | 103.02M | -0.69% | 34,257 | - |
| 366 | PEPG | PepGen Inc. | 101.68M | -2.65% | 226,219 | - |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 100.28M | -3.85% | 2,312,877 | 70.00M |
| 368 | VRCA | Verrica Pharmaceuticals Inc. | 98.43M | -4.98% | 49,862 | 37.16M |
| 369 | ONCY | Oncolytics Biotech Inc. | 95.84M | -2.07% | 652,396 | - |
| 370 | PTHS | Pelthos Therapeutics Inc. | 95.58M | -4.25% | 1,609 | 27.70M |
| 371 | VANI | Vivani Medical, Inc. | 94.86M | -2.65% | 120,833 | - |
| 372 | SEER | Seer, Inc. | 94.57M | 1.18% | 96,250 | 15.17M |
| 373 | CBUS | Cibus, Inc. | 93.89M | -1.60% | 301,643 | 3.64M |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 93.80M | -0.48% | 95,600 | 23.14M |
| 375 | PMN | ProMIS Neurosciences, Inc. | 92.82M | -3.27% | 17,664 | - |
| 376 | FBIO | Fortress Biotech, Inc. | 92.02M | 0.36% | 286,074 | 66.16M |
| 377 | CSBR | Champions Oncology, Inc. | 90.26M | 1.25% | 4,425 | 57.95M |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 90.13M | - | 1,113,083 | 65.34K |
| 379 | RNTX | Rein Therapeutics Inc. | 89.12M | 3.49% | 721,485 | - |
| 380 | PYPD | PolyPid Ltd. | 88.58M | 1.09% | 61,882 | - |
| 381 | ICCC | ImmuCell Corporation | 87.57M | -0.62% | 9,428 | 29.93M |
| 382 | AARD | Aardvark Therapeutics, Inc. | 85.08M | 7.14% | 130,083 | - |
| 383 | BMEA | Biomea Fusion, Inc. | 84.59M | -1.68% | 609,703 | - |
| 384 | ACET | Adicet Bio, Inc. | 84.53M | 6.62% | 121,739 | - |
| 385 | RLYB | Rallybio Corporation | 84.21M | - | 52,056 | 858.00K |
| 386 | ANIX | Anixa Biosciences, Inc. | 84.04M | -0.40% | 145,867 | - |
| 387 | NRXS | NeurAxis, Inc. | 82.98M | -2.76% | 65,795 | 4.28M |
| 388 | CUE | Cue Biopharma, Inc. | 79.85M | -9.45% | 86,602 | 32.73M |
| 389 | OKYO | OKYO Pharma Limited | 79.77M | -1.94% | 157,152 | - |
| 390 | MAIA | MAIA Biotechnology, Inc. | 79.04M | - | 399,738 | - |
| 391 | LONA | LeonaBio, Inc. | 78.44M | -1.65% | 15,563 | - |
| 392 | ATHE | Alterity Therapeutics Limited | 78.24M | 2.43% | 55,577 | 4.43M |
| 393 | HYFT | MindWalk Holdings Corp. | 77.48M | -4.88% | 271,539 | 20.70M |
| 394 | RANI | Rani Therapeutics Holdings, Inc. | 75.87M | -5.22% | 910,011 | 3.17M |
| 395 | HRTX | Heron Therapeutics, Inc. | 75.73M | -1.43% | 4,558,208 | 150.71M |
| 396 | ANVS | Annovis Bio, Inc. | 75.72M | -2.73% | 628,659 | - |
| 397 | OSTX | OS Therapies Incorporated | 75.71M | -0.58% | 279,442 | - |
| 398 | LIXT | Lixte Biotechnology Holdings, Inc. | 71.92M | -14.62% | 871,824 | - |
| 399 | GANX | Gain Therapeutics, Inc. | 71.66M | -0.59% | 482,863 | - |
| 400 | XBIT | XBiotech Inc. | 71.34M | 0.43% | 20,155 | - |
| 401 | PLRX | Pliant Therapeutics, Inc. | 69.97M | -0.88% | 207,257 | - |
| 402 | CING | Cingulate Inc. | 64.79M | -4.13% | 179,268 | - |
| 403 | BYSI | BeyondSpring Inc. | 64.56M | -4.85% | 14,427 | 1.88M |
| 404 | IMA | ImageneBio, Inc. | 63.39M | -1.58% | 13,307 | 800.00K |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 63.35M | 2.78% | 297,322 | - |
| 406 | IBO | Impact BioMedical Inc. | 63.08M | 4.46% | 54,473 | 39.00K |
| 407 | IBIO | iBio, Inc. | 61.08M | 1.20% | 455,655 | 300.00K |
| 408 | ENTX | Entera Bio Ltd. | 60.55M | 6.03% | 45,824 | 42.00K |
| 409 | MNOV | MediciNova, Inc. | 60.54M | -3.91% | 103,464 | 596.64K |
| 410 | FLNA | Filana Therapeutics, Inc. | 60.38M | -4.58% | 193,773 | - |
| 411 | EXOZ | eXoZymes, Inc. | 60.20M | -7.79% | 13,400 | -700.00 |
| 412 | INKT | MiNK Therapeutics, Inc. | 59.88M | -2.59% | 28,191 | - |
| 413 | TCRX | TScan Therapeutics, Inc. | 59.61M | -1.28% | 380,262 | 9.14M |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 59.20M | 1.83% | 120,534 | - |
| 415 | PDSB | PDS Biotechnology Corporation | 58.61M | -6.25% | 450,332 | - |
| 416 | MCRB | Seres Therapeutics, Inc. | 55.20M | -9.81% | 109,371 | 1.15M |
| 417 | ELOX | Eloxx Pharmaceuticals, Inc. | 54.57M | 6.96% | 51,449 | - |
| 418 | TIL | Instil Bio, Inc. | 53.71M | -0.13% | 12,411 | - |
| 419 | EDSA | Edesa Biotech, Inc. | 51.54M | 2.65% | 180,117 | - |
| 420 | DWTX | Dogwood Therapeutics, Inc. | 51.44M | -1.91% | 60,141 | - |
| 421 | RADX | Radiopharm Theranostics Limited | 50.00M | -2.73% | 22,978 | 10.86M |
| 422 | IMMP | Immutep Limited | 49.89M | 0.66% | 395,114 | 5.28M |
| 423 | XLO | Xilio Therapeutics, Inc. | 49.72M | 4.01% | 12,755 | 53.48M |
| 424 | LTRN | Lantern Pharma Inc. | 49.50M | -4.67% | 133,564 | - |
| 425 | KALA | KALA BIO, Inc. | 48.89M | 6.48% | 198,284 | - |
| 426 | MREO | Mereo BioPharma Group plc | 48.68M | -2.18% | 2,125,938 | 500.00K |
| 427 | ACTU | Actuate Therapeutics, Inc. | 48.33M | 1.51% | 1,203,546 | - |
| 428 | VERU | Veru Inc. | 48.15M | -7.98% | 728,937 | 16.89M |
| 429 | ESLA | Estrella Immunopharma, Inc. | 45.62M | -1.85% | 22,380 | - |
| 430 | MGX | Metagenomi Therapeutics, Inc. | 45.18M | -4.00% | 63,490 | 22.33M |
| 431 | GNTA | Genenta Science S.p.A. | 44.12M | -2.60% | 275,182 | - |
| 432 | TVGN | Tevogen Bio Holdings Inc. | 43.84M | -10.28% | 23,052 | - |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 43.32M | - | 142,389 | - |
| 434 | ATYR | aTyr Pharma, Inc. | 43.18M | -7.36% | 1,428,265 | 190.00K |
| 435 | NTRB | Nutriband Inc. | 41.21M | -3.69% | 6,290 | 1.80M |
| 436 | HYPD | Hyperion DeFi, Inc. | 38.64M | 2.26% | 319,738 | 1.04M |
| 437 | RNXT | RenovoRx, Inc. | 38.05M | -2.41% | 129,585 | 1.49M |
| 438 | GOSS | Gossamer Bio, Inc. | 38.00M | -8.74% | 18,116,671 | 55.54M |
| 439 | GRDX | GridAI Technologies Corp. | 35.06M | -10.68% | 80,804 | - |
| 440 | PSTV | Plus Therapeutics, Inc. | 34.48M | -7.56% | 98,603 | 5.18M |
| 441 | GRCE | Grace Therapeutics, Inc. | 34.04M | -4.35% | 412,679 | - |
| 442 | INMB | INmune Bio Inc. | 32.97M | -2.36% | 151,616 | 50.00K |
| 443 | ALGS | Aligos Therapeutics, Inc. | 32.67M | - | 76,681 | 4.71M |
| 444 | LSTA | Lisata Therapeutics, Inc. | 32.42M | 2.30% | 56,329 | 170.00K |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 31.69M | -2.88% | 199,244 | 90.00K |
| 446 | BOLD | Boundless Bio, Inc. | 31.61M | 1.44% | 11,472 | - |
| 447 | APLM | Apollomics, Inc. | 31.41M | 4.42% | 15,864 | 8.84M |
| 448 | EVAX | Evaxion A/S | 30.36M | 0.83% | 58,940 | 7.53M |
| 449 | DARE | Daré Bioscience, Inc. | 30.26M | -0.49% | 95,739 | 1.16M |
| 450 | ABVC | ABVC BioPharma, Inc. | 30.07M | -9.16% | 77,029 | 797.92K |
| 451 | SNTI | Senti Biosciences Holdings, Inc. | 29.90M | -2.47% | 76,628 | 38.00K |
| 452 | KYNB | Kyntra Bio, Inc. | 28.86M | 5.47% | 461,353 | 7.44M |
| 453 | NNVC | NanoViricides, Inc. | 27.79M | -10.95% | 422,631 | - |
| 454 | IGC | IGC Pharma, Inc. | 27.66M | -0.88% | 565,017 | 1.11M |
| 455 | SKYE | Skye Bioscience, Inc. | 27.65M | -1.54% | 121,829 | - |
| 456 | SER | Serina Therapeutics, Inc. | 27.41M | 1.66% | 161,863 | 130.00K |
| 457 | BRNS | Barinthus Biotherapeutics plc | 27.41M | -7.31% | 93,628 | 14.97M |
| 458 | NRSN | NeuroSense Therapeutics Ltd. | 25.99M | -0.51% | 181,902 | - |
| 459 | LITS | Lite Strategy, Inc. | 25.22M | 0.18% | 155,862 | - |
| 460 | DYAI | Dyadic International, Inc. | 24.85M | -0.04% | 103,653 | 3.81M |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 24.77M | -2.58% | 36,845 | - |
| 462 | QNTM | Quantum BioPharma Ltd. | 24.56M | -4.25% | 118,316 | - |
| 463 | PLUR | Pluri Inc. | 24.49M | 0.89% | 9,467 | 1.08M |
| 464 | LGVN | Longeveron Inc. | 24.38M | 1.49% | 135,362 | 1.22M |
| 465 | BCTX | BriaCell Therapeutics Corp. | 23.68M | 1.09% | 192,404 | - |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 23.62M | -2.67% | 42,992 | -13.27K |
| 467 | MRKR | Marker Therapeutics, Inc. | 23.01M | 0.73% | 28,511 | 3.55M |
| 468 | PTN | Palatin Technologies, Inc. | 22.88M | -0.55% | 6,875 | 12.88M |
| 469 | VTGN | Vistagen Therapeutics, Inc. | 22.83M | 0.54% | 681,286 | 789.00K |
| 470 | CRVO | CervoMed Inc. | 22.68M | 0.41% | 132,108 | 2.09M |
| 471 | ALLR | Allarity Therapeutics, Inc. | 22.11M | -7.74% | 341,607 | 345.00K |
| 472 | VYNE | VYNE Therapeutics Inc. | 21.61M | -2.47% | 82,899 | 454.00K |
| 473 | ATOS | Atossa Therapeutics, Inc. | 21.18M | -4.84% | 644,745 | - |
| 474 | PLRZ | Polyrizon Ltd. | 20.83M | -3.89% | 27,356 | - |
| 475 | CELU | Celularity Inc. | 20.64M | -1.91% | 35,479 | 26.55M |
| 476 | KTTA | Pasithea Therapeutics Corp. | 19.75M | -2.78% | 135,015 | - |
| 477 | TRAW | Traws Pharma, Inc. | 19.39M | 0.79% | 596,198 | 2.73M |
| 478 | AEON | AEON Biopharma, Inc. | 18.81M | 2.89% | 56,199 | - |
| 479 | PASG | Passage Bio, Inc. | 18.64M | 3.75% | 30,364 | - |
| 480 | LPCN | Lipocine Inc. | 18.63M | 2.73% | 203,729 | 2.00M |
| 481 | HOWL | Werewolf Therapeutics, Inc. | 18.52M | -3.35% | 426,798 | 1.14M |
| 482 | TPST | Tempest Therapeutics, Inc. | 18.07M | 0.80% | 37,770 | - |
| 483 | CLRB | Cellectar Biosciences, Inc. | 17.82M | -0.89% | 69,480 | - |
| 484 | XCUR | Exicure, Inc. | 17.72M | -1.42% | 24,924 | 500.00K |
| 485 | SNSE | Sensei Biotherapeutics, Inc. | 17.45M | 20.48% | 58,062 | - |
| 486 | NCEL | NewcelX Ltd. | 17.39M | -1.10% | 11,896 | - |
| 487 | CRIS | Curis, Inc. | 16.84M | -1.29% | 128,542 | 7.06M |
| 488 | HIND | Vyome Holdings, Inc. | 16.14M | 0.88% | 8,772 | 152.72K |
| 489 | GTBP | GT Biopharma, Inc. | 16.12M | 2.76% | 1,442,587 | - |
| 490 | MLEC | Moolec Science SA | 15.91M | 5.37% | 7,508 | 7.83M |
| 491 | CVM | CEL-SCI Corporation | 15.65M | -2.70% | 836,153 | - |
| 492 | AKTX | Akari Therapeutics, Plc | 15.34M | -9.58% | 112,887 | - |
| 493 | LEXX | Lexaria Bioscience Corp. | 15.23M | -4.12% | 96,697 | 368.00K |
| 494 | QNCX | Quince Therapeutics, Inc. | 15.22M | -1.40% | 377,786 | - |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 14.82M | -5.69% | 425,955 | 5.61M |
| 496 | BLRX | BioLineRx Ltd. | 14.37M | -2.88% | 51,293 | 1.40M |
| 497 | MBRX | Moleculin Biotech, Inc. | 14.09M | -2.22% | 199,609 | - |
| 498 | INAB | IN8bio, Inc. | 14.08M | -0.69% | 14,085 | - |
| 499 | TOVX | Theriva Biologics, Inc. | 13.94M | -1.04% | 7,639,927 | 300.00K |
| 500 | CYCN | Cyclerion Therapeutics, Inc. | 13.78M | 1.25% | 39,098 | 1.99M |